Bruce Altevogt is Vice President and Head External Engagement within Pfizer Inc.’s Internal Medicine and Hospital Medical Affairs. In this role Dr. Altevogt is responsible for establishing and managing the business unit’s patient and medical stakeholder engagement strategy. Prior to this role served as a Senior Director of Science Policy and Science Advocacy, where he managed policy issues in support of Pfizer’s research & development enterprise, vaccines and was lead for anti-microbial resistance policy. Dr. Altevogt serves as Secretary of the Healthcare Ready Board, a non-profit organization that helps to strengthen healthcare supply chains by addressing pressing issues before, during, and after disasters. Prior to joining Pfizer Inc. Dr. Altevogt served as a senior program officer on the Board on Health Sciences Policy at the Institute of Medicine (IOM). While at the IOM he led policy initiatives related to basic and translational research, drug discovery and development, and preparedness for catastrophic events. He oversaw the publication of over 50 IOM reports and directed multiple IOM studies. In his capacity at the IOM he served as director of the Forum on Medical and Public Health Preparedness for Catastrophic Events, the Forum on Neuroscience and Nervous System Disorders Forum, and number or additional activities.

Dr. Altevogt received a doctorate from Harvard University’s Program in Neuroscience and a B.A. from the University of Virginia, where he majored in Biology and minored in South Asian Studies. He is a published author of multiple scientific articles.